Selena E. Bartlett - Publications

Ernest Gallo Clinic and Research Center, Emeryville, CA, United States 
Alcoholism, Addiction, Translational Research

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Patkar OL, Belmer A, Holgate JY, Klenowski PM, Bartlett SE. Modulation of serotonin and noradrenaline in the BLA by pindolol reduces long-term ethanol intake. Addiction Biology. PMID 30022582 DOI: 10.1111/Adb.12630  0.334
2017 Tarren JR, Lester HA, Belmer A, Bartlett SE. Acute Ethanol Administration Upregulates Synaptic α4-Subunit of Neuronal Nicotinic Acetylcholine Receptors within the Nucleus Accumbens and Amygdala. Frontiers in Molecular Neuroscience. 10: 338. PMID 29114204 DOI: 10.3389/Fnmol.2017.00338  0.348
2017 Holgate JY, Garcia H, Chatterjee S, Bartlett SE. Social and environmental enrichment has different effects on ethanol and sucrose consumption in mice. Brain and Behavior. 7: e00767. PMID 28828224 DOI: 10.1002/Brb3.767  0.304
2017 Shariff M, Klenowski P, Morgan M, Patkar O, Mu E, Bellingham M, Belmer A, Bartlett SE. Binge-like sucrose consumption reduces the dendritic length and complexity of principal neurons in the adolescent rat basolateral amygdala. Plos One. 12: e0183063. PMID 28813474 DOI: 10.1371/Journal.Pone.0183063  0.308
2016 Haass-Koffler CL, Henry AT, Melkus G, Simms JA, Naemmuddin M, Nielsen CK, Lasek AW, Magill M, Schwandt ML, Momenan R, Hodgkinson CA, Bartlett SE, Swift RM, Bonci A, Leggio L. Defining the role of corticotropin releasing factor binding protein in alcohol consumption. Translational Psychiatry. 6: e953. PMID 27845775 DOI: 10.1038/Tp.2016.208  0.373
2016 Patkar OL, Belmer A, Holgate JY, Tarren JR, Shariff MR, Morgan M, Fogarty MJ, Bellingham MC, Bartlett SE, Klenowski PM. The antihypertensive drug pindolol attenuates long-term but not short-term binge-like ethanol consumption in mice. Addiction Biology. PMID 27273539 DOI: 10.1111/Adb.12359  0.365
2016 Gowin JL, Vatsalya V, Westman JG, Schwandt ML, Bartlett S, Heilig M, Momenan R, Ramchandani VA. The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers. Alcoholism, Clinical and Experimental Research. PMID 27062270 DOI: 10.1111/Acer.13046  0.3
2016 Klenowski PM, Shariff MR, Belmer A, Fogarty MJ, Mu EW, Bellingham MC, Bartlett SE. Prolonged Consumption of Sucrose in a Binge-Like Manner, Alters the Morphology of Medium Spiny Neurons in the Nucleus Accumbens Shell. Frontiers in Behavioral Neuroscience. 10: 54. PMID 27047355 DOI: 10.3389/Fnbeh.2016.00054  0.31
2016 Shariff M, Quik M, Holgate J, Morgan M, Patkar OL, Tam V, Belmer A, Bartlett SE. Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake. Plos One. 11: e0150270. PMID 27028298 DOI: 10.1371/Journal.Pone.0150270  0.326
2015 Klenowski P, Morgan M, Bartlett SE. The role of δ-opioid receptors in learning and memory underlying the development of addiction. British Journal of Pharmacology. 172: 297-310. PMID 24641428 DOI: 10.1111/Bph.12618  0.324
2015 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. British Journal of Pharmacology. 172: 334-48. PMID 24641197 DOI: 10.1111/Bph.12639  0.322
2014 Feduccia AA, Simms JA, Mill D, Yi HY, Bartlett SE. Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens. British Journal of Pharmacology. 171: 3420-31. PMID 24628360 DOI: 10.1111/Bph.12690  0.342
2014 Simms JA, Nielsen CK, Li R, Bartlett SE. Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. Addiction Biology. 19: 606-11. PMID 23362976 DOI: 10.1111/Adb.12024  0.346
2013 Mill DJ, Bito-Onon JJ, Simms JA, Li R, Bartlett SE. Fischer rats consume 20% ethanol in a long-term intermittent-access two-bottle-choice paradigm. Plos One. 8: e79824. PMID 24244567 DOI: 10.1371/Journal.Pone.0079824  0.325
2013 Santos N, Chatterjee S, Henry A, Holgate J, Bartlett SE. The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice. Alcoholism, Clinical and Experimental Research. 37: 655-62. PMID 23164049 DOI: 10.1111/Acer.12009  0.347
2013 Bartlett S, Heilig M. Translational approaches to medication development. Current Topics in Behavioral Neurosciences. 13: 543-82. PMID 21590390 DOI: 10.1007/978-3-642-28720-6_132  0.305
2012 Srinivasan S, Simms JA, Nielsen CK, Lieske SP, Bito-Onon JJ, Yi H, Hopf FW, Bonci A, Bartlett SE. The dual orexin/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration. Plos One. 7: e44726. PMID 23028593 DOI: 10.1371/Journal.Pone.0044726  0.342
2012 Feduccia AA, Chatterjee S, Bartlett SE. Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions. Frontiers in Molecular Neuroscience. 5: 83. PMID 22876217 DOI: 10.3389/Fnmol.2012.00083  0.336
2012 Feduccia AA, Wang Y, Simms JA, Yi HY, Li R, Bjeldanes L, Ye C, Bartlett SE. Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: involvement of adenosine and dopamine receptors. Pharmacology, Biochemistry, and Behavior. 102: 241-8. PMID 22579816 DOI: 10.1016/J.Pbb.2012.04.014  0.338
2012 Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL. Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology. 223: 299-306. PMID 22547331 DOI: 10.1007/S00213-012-2717-X  0.302
2012 Nielsen CK, Simms JA, Li R, Mill D, Yi H, Feduccia AA, Santos N, Bartlett SE. δ-opioid receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 4540-52. PMID 22457501 DOI: 10.1523/Jneurosci.5345-11.2012  0.331
2012 Simms JA, Haass-Koffler CL, Bito-Onon J, Li R, Bartlett SE. Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 906-18. PMID 22048462 DOI: 10.1038/Npp.2011.268  0.358
2012 Nielsen CK, Simms JA, Bito-Onon JJ, Li R, Ananthan S, Bartlett SE. The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking. Addiction Biology. 17: 224-34. PMID 21309957 DOI: 10.1111/J.1369-1600.2010.00295.X  0.36
2012 Landgren S, Simms JA, Hyytiä P, Engel JA, Bartlett SE, Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. Addiction Biology. 17: 86-94. PMID 21309944 DOI: 10.1111/J.1369-1600.2010.00280.X  0.311
2011 Mahmoud S, Thorsell A, Sommer WH, Heilig M, Holgate JK, Bartlett SE, Ruiz-Velasco V. Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons. Anesthesiology. 115: 1054-62. PMID 21926562 DOI: 10.1097/Aln.0B013E318231Fc11  0.335
2011 Simms JA, Richards JK, Mill D, Kanholm I, Holgate JY, Bartlett SE. Induction of multiple reinstatements of ethanol- and sucrose-seeking behavior in Long-Evans rats by the α-2 adrenoreceptor antagonist yohimbine. Psychopharmacology. 218: 101-10. PMID 21863233 DOI: 10.1007/S00213-011-2451-9  0.33
2011 Enquist J, Kim JA, Bartlett S, Ferwerda M, Whistler JL. A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 338: 633-40. PMID 21562138 DOI: 10.1124/Jpet.111.179754  0.326
2011 Landgren S, Simms JA, Thelle DS, Strandhagen E, Bartlett SE, Engel JA, Jerlhag E. The ghrelin signalling system is involved in the consumption of sweets. Plos One. 6: e18170. PMID 21448464 DOI: 10.1371/Journal.Pone.0018170  0.332
2011 Bito-Onon JJ, Simms JA, Chatterjee S, Holgate J, Bartlett SE. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. Addiction Biology. 16: 440-9. PMID 21392178 DOI: 10.1111/J.1369-1600.2010.00309.X  0.354
2011 Hopf FW, Simms JA, Chang SJ, Seif T, Bartlett SE, Bonci A. Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biological Psychiatry. 69: 618-24. PMID 21195386 DOI: 10.1016/J.Biopsych.2010.11.011  0.307
2011 Chatterjee S, Steensland P, Simms JA, Holgate J, Coe JW, Hurst RS, Shaffer CL, Lowe J, Rollema H, Bartlett SE. Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 603-15. PMID 21048701 DOI: 10.1038/Npp.2010.191  0.376
2010 Steensland P, Simms JA, Nielsen CK, Holgate J, Bito-Onon JJ, Bartlett SE. The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol. Plos One. 5. PMID 20824145 DOI: 10.1371/Journal.Pone.0012527  0.362
2010 Chatterjee S, Bartlett SE. Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. Cns & Neurological Disorders Drug Targets. 9: 60-76. PMID 20201817 DOI: 10.2174/187152710790966597  0.323
2010 Simms JA, Bito-Onon JJ, Chatterjee S, Bartlett SE. Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1453-63. PMID 20200505 DOI: 10.1038/Npp.2010.15  0.322
2009 Corl AB, Berger KH, Ophir-Shohat G, Gesch J, Simms JA, Bartlett SE, Heberlein U. Happyhour, a Ste20 family kinase, implicates EGFR signaling in ethanol-induced behaviors. Cell. 137: 949-60. PMID 19464045 DOI: 10.1016/J.Cell.2009.03.020  0.331
2009 Carnicella S, Ahmadiantehrani S, He DY, Nielsen CK, Bartlett SE, Janak PH, Ron D. Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. Biological Psychiatry. 66: 146-53. PMID 19232578 DOI: 10.1016/J.Biopsych.2008.12.022  0.315
2009 Richards JK, Simms JA, Bartlett SE. Conditioned cues and yohimbine induce reinstatement of beer and near-beer seeking in Long-Evans rats. Addiction Biology. 14: 144-51. PMID 19076928 DOI: 10.1111/J.1369-1600.2008.00139.X  0.328
2008 Nielsen CK, Simms JA, Pierson HB, Li R, Saini SK, Ananthan S, Bartlett SE. A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. Biological Psychiatry. 64: 974-81. PMID 18774553 DOI: 10.1016/J.Biopsych.2008.07.018  0.384
2008 Simms JA, Steensland P, Medina B, Abernathy KE, Chandler LJ, Wise R, Bartlett SE. Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcoholism, Clinical and Experimental Research. 32: 1816-23. PMID 18671810 DOI: 10.1111/J.1530-0277.2008.00753.X  0.324
2008 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology. 199: 109-17. PMID 18470506 DOI: 10.1007/S00213-008-1136-5  0.348
2008 Kim JA, Bartlett S, He L, Nielsen CK, Chang AM, Kharazia V, Waldhoer M, Ou CJ, Taylor S, Ferwerda M, Cado D, Whistler JL. Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Current Biology : Cb. 18: 129-35. PMID 18207746 DOI: 10.1016/J.Cub.2007.12.057  0.337
2007 Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proceedings of the National Academy of Sciences of the United States of America. 104: 12518-23. PMID 17626178 DOI: 10.1073/Pnas.0705368104  0.361
2004 Leck KJ, Bartlett SE, Smith MT, Megirian D, Holgate J, Powell KL, Matthaei KI, Hendry IA. Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine. Neuropharmacology. 46: 836-46. PMID 15033343 DOI: 10.1016/J.Neuropharm.2003.11.024  0.488
1999 Halliday AJ, Bartlett SE, Colditz P, Smith MT. Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide. Life Sciences. 65: 225-36. PMID 10416828 DOI: 10.1016/S0024-3205(99)00239-8  0.508
1996 Bartlett SE, Smith MT. Effects of morphine-3-glucuronide and morphine on the K+-evoked release of [3H]-glutamic acid and [14C]-gamma-aminobutyric acid from rat brain synaptosomes. Life Sciences. 58: 447-54. PMID 8594310 DOI: 10.1016/0024-3205(95)02310-0  0.475
1995 Bartlett SE, Smith MT. The apparent affinity of morphine-3-glucuronide at mu1-opioid receptors results from morphine contamination: demonstration using HPLC and radioligand binding. Life Sciences. 57: 609-15. PMID 7623628 DOI: 10.1016/0024-3205(95)00311-S  0.484
1994 Bartlett SE, Cramond T, Smith MT. The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sciences. 54: 687-94. PMID 8107513 DOI: 10.1016/0024-3205(94)00552-4  0.669
1994 Bartlett SE, Dodd PR, Smith MT. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Pharmacology & Toxicology. 75: 73-81. PMID 7971741 DOI: 10.1111/J.1600-0773.1994.Tb00327.X  0.502
Show low-probability matches.